mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.003 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.003 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |